Peptides as Immunogens: Prospects for Synthetic Vaccines

  • R. Arnon
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 130)


The basis for the utilization of synthetic peptides as immunogens was laid during our early studies on the antigenicity of proteins. The initial findings that covalent attachment of tyrosine oligopeptides to gelatin by polymeric techniques resulted in augmentation of its immunogenicity (SELA and ARNON 1960) led us to the synthesis of both linear and branched polymers of amino acids, capable of initiating an immune response (SELA et al. 1962). The availability of these synthetic antigens permitted a systematic elucidation of the molecular basis of antigenicity, including the role of such variables as chemical composition, size, shape, accessibility of epitopes, electrical Charge, optical configuration, and mainly spatial conformation in rendering a molecule immunogenic and in dictating its antigenic specificity (SELA 1969).


Synthetic Peptide Cholera Toxin Antigenic Determinant Antigenic Site Intact Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ada GL, Leung KN, Ertl H (1981) Imm Rev 58:5CrossRefGoogle Scholar
  2. Altschuh D, Hartman D, Reinbolt J, Van Regenmortel MHV (1983) Mol Immunol 20:271PubMedCrossRefGoogle Scholar
  3. Arnon R (1972) In:Kohen A, Klingberg AM (eds) Immunity of viral and rickettsial diseases. Plenum Press, New York, pp 209Google Scholar
  4. Arnon R (1974) In:Lotan N, Goodman M, Blout ER (eds) Peptides, polypeptides and proteins. Wiley 1974. pp 538Google Scholar
  5. Arnon R (1985) In:Van Regenmortel MHV, Neurath AR (eds) Immunochemistry of viruses:the basis for serodiagnosis and vaccines. Elsevier, New York, pp 139Google Scholar
  6. Arnon R, Sela M (1969) Proc Natl Acad Sei USA 62:163CrossRefGoogle Scholar
  7. Arnon R, Maron E, Sela M, Anfmsen CB (1971) Proc Natl Acad Sei USA 68:1450CrossRefGoogle Scholar
  8. Arnon R, Bustin M, Calef E, Chaitchik S, Haimovich J, Novik N, Sela M (1976) Proc Soc Natl Acad Sei USA 73:2123CrossRefGoogle Scholar
  9. Arnon R, Sela M, Parant M, Chedid L (1980) Proc Natl Acad Sei USA 77:6769–6772CrossRefGoogle Scholar
  10. Atasi MZ (1975) Immunochemistry 12:423CrossRefGoogle Scholar
  11. Atassi MZ, Smith JA (1978) Immunochemistry 15:609PubMedCrossRefGoogle Scholar
  12. Audibert F, Jolivet M, Chedid L, Alouf JE, Boquet P, Rivaille P, Shiffert O (1981) Nature 289:593PubMedCrossRefGoogle Scholar
  13. Audibert F, Jolivet M, Chedid L, Arnon R, Sela M (1982) Proc Natl Acad Sei USA 79:5052CrossRefGoogle Scholar
  14. Benjamini E (1977) In:Attasi MZ (ed) Immunochemistry of Proteins, vol 2. Plenum Press, New York, pp 265Google Scholar
  15. Benjamini E, Young JD, Simizu M, Leung CY (1964) Biochemistry 3:1115PubMedCrossRefGoogle Scholar
  16. Carelli C, Audibert F, Faillard J, Chedid L (1982) Intl J Immunopharmacol 4:290CrossRefGoogle Scholar
  17. Chedid L, Audibert F, Johnson AG (1978) Progr Allergy 25:63–105Google Scholar
  18. Crumpton MJ (1974) In:Sela M (ed) The antigens, vol 2. Academic Press, New York, pp 1Google Scholar
  19. Crumpton MJ, Wilkinson JM (1966) Biochem J 100:223PubMedGoogle Scholar
  20. Ellouz F, Adam A, Ciorbaru R, Lederer E (1974) Biochem Biophys Res Comm 55:1317CrossRefGoogle Scholar
  21. Emini EA, Jameson BA, Wimmer E (1983) Nature 304:699PubMedCrossRefGoogle Scholar
  22. Geyssen HM, Meloen RH, Basteling SJ (1984) Proc Natl Acad Sei USA 81:3998CrossRefGoogle Scholar
  23. Geyssen HM, Rodda SJ, Mason TJ (1986) In:Porter R, Whelan J (eds) Synthetic peptides as antigens, Ciba Foundation Symposium, Pitman, London (in press)Google Scholar
  24. Green N, Alexander H, Olson A, Alexander S, Shinnick TM, Sutcliffe JG, Lerner RA (1982) Cell 28:477PubMedCrossRefGoogle Scholar
  25. Hopp TP, Woods KR (1981) Proc Natl Acad Sei 78:3824CrossRefGoogle Scholar
  26. Jackson DC, Brown LE, White DO, Dopheide TAA, Ward CW (1979) J Immunol 123:2610PubMedGoogle Scholar
  27. Jackson DC, Murray JM, White DO, Fagan CN, Tregear GW (1982) Virology 120:272CrossRefGoogle Scholar
  28. Jacob CO, Sela M, Arnon R (1983) Proc Natl Acad Sei USA 80:7611CrossRefGoogle Scholar
  29. Jacob CO, Pines M, Arnon R (1984a) EMBO J 3:2889PubMedGoogle Scholar
  30. Jacob CO, Sela M, Pines M, Hurwitz S, Arnon R (1984b) Proc Natl Acad Sei USA 81:7893CrossRefGoogle Scholar
  31. Jacob CO, Harari I, Arnon R, Sela M (1986 a) Vaccine 4:95Google Scholar
  32. Jacob CO, Grossfeld S, Sela M, Arnon R (1986 b) (in press)Google Scholar
  33. Karplus PA, Schulz GE (1985) Naturwissenschaften 72:212CrossRefGoogle Scholar
  34. Langbeheim H, Arnon R, Sela M (1976) Proc Natl Acad Sei USA 73:4636CrossRefGoogle Scholar
  35. Laver GW, Air GM (eds) (1979) Structure and variations in influenza virus. Elesevier, North Holland Laver WG, Valentine RC (1969) Virology 38:105Google Scholar
  36. Laver WG, Air GM, Dopheide TA, Ward CW (1980) Nature 283:454PubMedCrossRefGoogle Scholar
  37. Laver WG, Air GM, Webster RG (1981) J Mol Biol 145:339PubMedCrossRefGoogle Scholar
  38. Lerner RA, Green N, Alexander H, Liu FT, Sutcliffe GJ, Shinnick TM (1981) Proc Nat Acad Sei USA 78:3403CrossRefGoogle Scholar
  39. Maron E, Shiozawa C, Arnon R, Sela M (1971) Biochemistry 10:763PubMedCrossRefGoogle Scholar
  40. Müller GM, Shapira M, Arnon R (1982) Proc Natl Acad Sei USA 79:569CrossRefGoogle Scholar
  41. Pecht I, Maron E, Arnon R, Sela M (1971) Eur J Biochem 19:369CrossRefGoogle Scholar
  42. Rose GD (1978) Nature 272:586PubMedCrossRefGoogle Scholar
  43. Sela M (1969) Science 166:1365PubMedCrossRefGoogle Scholar
  44. Sela M, Arnon R (1960) Biochim Biophys Acta 40:382PubMedCrossRefGoogle Scholar
  45. Sela M, Fuchs S, Arnon R (1962) Biochem J 85:323Google Scholar
  46. Sela M, Sehechter B, Schechter I, Borek F (1967) Cold Spring Harbor, Symp on Quant Biol 32, 537Google Scholar
  47. Shapira M, Arnon R (1985) Mol Immunol 22:23–28PubMedCrossRefGoogle Scholar
  48. Shapira M, Jolivert M, Arnon R (1986) Intl J Immunopharmacol (in press)Google Scholar
  49. Shinka S, Imanishi M, Kuwahara O, Fujio H, Amano T (1962) Biken, J 5, 181Google Scholar
  50. Trainer JA, Getzoff ED, Alexander H, Houghten RA, Olson AJ, Lerner RA, Hendrickson WA (1984) Nature 312:127CrossRefGoogle Scholar
  51. Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, Klug A, Van Regenmortel MHV (1984) Nature 311:123PubMedCrossRefGoogle Scholar
  52. Wiley DC, Wilson IA, Skehel JJ (1981) Nature 289:373PubMedCrossRefGoogle Scholar
  53. Wilson IA, Skehel JJ, Wiley DC (1981) Nature 289:366PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • R. Arnon
    • 1
  1. 1.Department of Chemical ImmunologyWeizmann Institute of ScienceRehovotIsrael

Personalised recommendations